Our study demonstrated similar results, CXCR3 knockdowns inhibited CRC cell migration, while CXCR3 inhibitors diminished CD8+ T cell infiltration and facilitated tumor metastasis. The gene discussed is CD8A; the disease is colorectal carcinoma.